Weekly Research Email
Did a colleague forward this email to you?
Get your own by signing up here ».
 With healthcare reform projected to cost $950 billion, the pharma, device and hospital industries have generally consented to help fund the changes - in the device industry's case, to the tune of $20 billion over the next decade, which will be realized through an excise tax proposed to be implemented in 2011. AdvaMed is pushing on behalf of the industry to lock in that $20 billion as a cap, reports Reuters. more
See related posts on Legislation
 Wear debris and surgical technique are at the center of a New York Times article on metal-on-metal total hip components, with the paper suggesting that metal-on-metal correlates to poorer outcomes and higher revision rates. The article cites a metal-on-metal revision rate of 1-3%, with women affected more frequently than men. more
See related posts on Hip
The NIH and FDA plan to collaborate on ways to bring innovative products to market sooner.  Among other actions, the two agencies plan to create a Joint Leadership Council, which will focus on encouraging researchers to think about regulatory issues early in the technology development cycle. The council will also work to incorporate the latest scientific data into the FDA review process. more
See related posts on FDA
 Baxter announced plans to acquire ApaTech for up to $330 million, with $240 million in cash up front (a 4x revenue multiple) and additional milestone payments of up to $90 million. more
See related posts on Biologics | Most Popular
 Dentsply reported 4Q:09 sales of $568.7 million, up 12% over the year-ago period and beating estimates by $12.0 million. Chairman and CEO Bret Wise commented, "We are pleased to report stronger sales and earnings for the fourth quarter, as we are beginning to see the initial signs of recovery in select markets and regions." more
See related posts on Clinical Studies | Dental | Most Popular | Nobel Biocare | Zimmer
|
Conference Calendar
March 13-13 - AOFAS Specialty Day
March 13-13 - Meeting of the Hip Society and AAHKS
Complete Calendar »
Earnings Calendar
|
This communication is neither an offer to sell nor a solicitation of an offer to buy any securities nor is it any form of investment recommendation. The information contained herein has been obtained from sources that we believe to be reliable but we do not guarantee its accuracy or completeness. HealthpointCapital, and/or affiliates may have a position in the securities of the company or companies described herein. Available information supporting this report will be furnished upon request. This report is not directed to, nor is it intended for distribution to or for use by any person or entity who is a citizen or resident or located in any state, country or other jurisdiction where such distribution, publication, availability or use would be contrary to law or regulation or which would subject HealthpointCapital, or its affiliates to any registration or licensing requirement within such jurisdiction. HealthpointCapital may seek to provide consulting services for the companies mentioned herein.
The latest news from AAOS! VITA and MAKO report 4Q09 . . . ETEX receives 510(k) . . . DePuy, Integra, Medtronic, Smith & Nephew and more announce product launches . . . SEC Drops Wright Medical Investigation . . . BioMimetic Therapeutics shares study results . . . Long-term use of bisphosphonates may increase fracture risk . . . NeoStem wins research grant 
Corin, Osteotech and Integra report 4Q . . . Baxter to 